nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—Torsade de pointes—Vandetanib—thyroid cancer	0.0268	0.0268	CcSEcCtD
Alfuzosin—Laryngitis—Vandetanib—thyroid cancer	0.026	0.026	CcSEcCtD
Alfuzosin—Ventricular arrhythmia—Vandetanib—thyroid cancer	0.0254	0.0254	CcSEcCtD
Alfuzosin—Nephrolithiasis—Vandetanib—thyroid cancer	0.0233	0.0233	CcSEcCtD
Alfuzosin—Atrial fibrillation—Vandetanib—thyroid cancer	0.0144	0.0144	CcSEcCtD
Alfuzosin—Influenza like illness—Sorafenib—thyroid cancer	0.0123	0.0123	CcSEcCtD
Alfuzosin—Neuropathy—Sorafenib—thyroid cancer	0.0119	0.0119	CcSEcCtD
Alfuzosin—Bronchitis—Vandetanib—thyroid cancer	0.0113	0.0113	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.0109	0.0109	CcSEcCtD
Alfuzosin—Infestation NOS—Vandetanib—thyroid cancer	0.0105	0.0105	CcSEcCtD
Alfuzosin—Infestation—Vandetanib—thyroid cancer	0.0105	0.0105	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00993	0.00993	CcSEcCtD
Alfuzosin—Sinusitis—Vandetanib—thyroid cancer	0.00985	0.00985	CcSEcCtD
Alfuzosin—Urinary tract disorder—Vandetanib—thyroid cancer	0.00931	0.00931	CcSEcCtD
Alfuzosin—Urethral disorder—Vandetanib—thyroid cancer	0.00924	0.00924	CcSEcCtD
Alfuzosin—Eye disorder—Vandetanib—thyroid cancer	0.00881	0.00881	CcSEcCtD
Alfuzosin—Cardiac disorder—Vandetanib—thyroid cancer	0.00875	0.00875	CcSEcCtD
Alfuzosin—Angiopathy—Vandetanib—thyroid cancer	0.00855	0.00855	CcSEcCtD
Alfuzosin—Mediastinal disorder—Vandetanib—thyroid cancer	0.00849	0.00849	CcSEcCtD
Alfuzosin—Abdominal pain upper—Sorafenib—thyroid cancer	0.00839	0.00839	CcSEcCtD
Alfuzosin—Breast disorder—Sorafenib—thyroid cancer	0.0083	0.0083	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00827	0.00827	CcSEcCtD
Alfuzosin—Mental disorder—Vandetanib—thyroid cancer	0.00826	0.00826	CcSEcCtD
Alfuzosin—Erectile dysfunction—Sorafenib—thyroid cancer	0.00731	0.00731	CcSEcCtD
Alfuzosin—Loss of consciousness—Vandetanib—thyroid cancer	0.00721	0.00721	CcSEcCtD
Alfuzosin—Infestation NOS—Sorafenib—thyroid cancer	0.00708	0.00708	CcSEcCtD
Alfuzosin—Infestation—Sorafenib—thyroid cancer	0.00708	0.00708	CcSEcCtD
Alfuzosin—Chest pain—Vandetanib—thyroid cancer	0.00698	0.00698	CcSEcCtD
Alfuzosin—Arthralgia—Vandetanib—thyroid cancer	0.00698	0.00698	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00694	0.00694	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00694	0.00694	CcSEcCtD
Alfuzosin—Jaundice—Sorafenib—thyroid cancer	0.0069	0.0069	CcSEcCtD
Alfuzosin—Dry mouth—Vandetanib—thyroid cancer	0.00683	0.00683	CcSEcCtD
Alfuzosin—Neuralgia—Epirubicin—thyroid cancer	0.00673	0.00673	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Sorafenib—thyroid cancer	0.0067	0.0067	CcSEcCtD
Alfuzosin—Oedema—Vandetanib—thyroid cancer	0.0067	0.0067	CcSEcCtD
Alfuzosin—Infection—Vandetanib—thyroid cancer	0.00665	0.00665	CcSEcCtD
Alfuzosin—Nervous system disorder—Vandetanib—thyroid cancer	0.00657	0.00657	CcSEcCtD
Alfuzosin—Thrombocytopenia—Vandetanib—thyroid cancer	0.00656	0.00656	CcSEcCtD
Alfuzosin—Skin disorder—Vandetanib—thyroid cancer	0.0065	0.0065	CcSEcCtD
Alfuzosin—Laryngitis—Epirubicin—thyroid cancer	0.00649	0.00649	CcSEcCtD
Alfuzosin—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.00632	0.00632	CcSEcCtD
Alfuzosin—Urinary tract disorder—Sorafenib—thyroid cancer	0.00628	0.00628	CcSEcCtD
Alfuzosin—Connective tissue disorder—Sorafenib—thyroid cancer	0.00625	0.00625	CcSEcCtD
Alfuzosin—Urethral disorder—Sorafenib—thyroid cancer	0.00623	0.00623	CcSEcCtD
Alfuzosin—Neuralgia—Doxorubicin—thyroid cancer	0.00623	0.00623	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.0061	0.0061	CcSEcCtD
Alfuzosin—Laryngitis—Doxorubicin—thyroid cancer	0.00601	0.00601	CcSEcCtD
Alfuzosin—Flushing—Sorafenib—thyroid cancer	0.0059	0.0059	CcSEcCtD
Alfuzosin—Cardiac disorder—Sorafenib—thyroid cancer	0.0059	0.0059	CcSEcCtD
Alfuzosin—Dyspepsia—Vandetanib—thyroid cancer	0.00589	0.00589	CcSEcCtD
Alfuzosin—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.00585	0.00585	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00578	0.00578	CcSEcCtD
Alfuzosin—Fatigue—Vandetanib—thyroid cancer	0.00577	0.00577	CcSEcCtD
Alfuzosin—Angiopathy—Sorafenib—thyroid cancer	0.00577	0.00577	CcSEcCtD
Alfuzosin—Mediastinal disorder—Sorafenib—thyroid cancer	0.00573	0.00573	CcSEcCtD
Alfuzosin—Pain—Vandetanib—thyroid cancer	0.00573	0.00573	CcSEcCtD
Alfuzosin—Constipation—Vandetanib—thyroid cancer	0.00573	0.00573	CcSEcCtD
Alfuzosin—Mental disorder—Sorafenib—thyroid cancer	0.00557	0.00557	CcSEcCtD
Alfuzosin—Liver injury—Epirubicin—thyroid cancer	0.00556	0.00556	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00547	0.00547	CcSEcCtD
Alfuzosin—Cardiovascular disorder—Epirubicin—thyroid cancer	0.00532	0.00532	CcSEcCtD
Alfuzosin—Abdominal pain—Vandetanib—thyroid cancer	0.00529	0.00529	CcSEcCtD
Alfuzosin—Arthropathy—Epirubicin—thyroid cancer	0.00514	0.00514	CcSEcCtD
Alfuzosin—Liver injury—Doxorubicin—thyroid cancer	0.00514	0.00514	CcSEcCtD
Alfuzosin—Angioedema—Sorafenib—thyroid cancer	0.00506	0.00506	CcSEcCtD
Alfuzosin—Syncope—Sorafenib—thyroid cancer	0.00496	0.00496	CcSEcCtD
Alfuzosin—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.00493	0.00493	CcSEcCtD
Alfuzosin—Loss of consciousness—Sorafenib—thyroid cancer	0.00486	0.00486	CcSEcCtD
Alfuzosin—Asthenia—Vandetanib—thyroid cancer	0.0048	0.0048	CcSEcCtD
Alfuzosin—Arthropathy—Doxorubicin—thyroid cancer	0.00476	0.00476	CcSEcCtD
Alfuzosin—Pruritus—Vandetanib—thyroid cancer	0.00474	0.00474	CcSEcCtD
Alfuzosin—Arthralgia—Sorafenib—thyroid cancer	0.00471	0.00471	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00468	0.00468	CcSEcCtD
Alfuzosin—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00468	0.00468	CcSEcCtD
Alfuzosin—Hepatocellular injury—Epirubicin—thyroid cancer	0.00468	0.00468	CcSEcCtD
Alfuzosin—Dry mouth—Sorafenib—thyroid cancer	0.00461	0.00461	CcSEcCtD
Alfuzosin—Diarrhoea—Vandetanib—thyroid cancer	0.00458	0.00458	CcSEcCtD
Alfuzosin—Influenza like illness—Epirubicin—thyroid cancer	0.00454	0.00454	CcSEcCtD
Alfuzosin—Infection—Sorafenib—thyroid cancer	0.00449	0.00449	CcSEcCtD
Alfuzosin—Shock—Sorafenib—thyroid cancer	0.00444	0.00444	CcSEcCtD
Alfuzosin—Nervous system disorder—Sorafenib—thyroid cancer	0.00443	0.00443	CcSEcCtD
Alfuzosin—Dizziness—Vandetanib—thyroid cancer	0.00443	0.00443	CcSEcCtD
Alfuzosin—Thrombocytopenia—Sorafenib—thyroid cancer	0.00442	0.00442	CcSEcCtD
Alfuzosin—Neuropathy—Epirubicin—thyroid cancer	0.00439	0.00439	CcSEcCtD
Alfuzosin—Skin disorder—Sorafenib—thyroid cancer	0.00439	0.00439	CcSEcCtD
Alfuzosin—Hepatocellular injury—Doxorubicin—thyroid cancer	0.00433	0.00433	CcSEcCtD
Alfuzosin—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00433	0.00433	CcSEcCtD
Alfuzosin—Vomiting—Vandetanib—thyroid cancer	0.00426	0.00426	CcSEcCtD
Alfuzosin—Rash—Vandetanib—thyroid cancer	0.00422	0.00422	CcSEcCtD
Alfuzosin—Dermatitis—Vandetanib—thyroid cancer	0.00422	0.00422	CcSEcCtD
Alfuzosin—Influenza like illness—Doxorubicin—thyroid cancer	0.0042	0.0042	CcSEcCtD
Alfuzosin—Headache—Vandetanib—thyroid cancer	0.00419	0.00419	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00411	0.00411	CcSEcCtD
Alfuzosin—Neuropathy—Doxorubicin—thyroid cancer	0.00406	0.00406	CcSEcCtD
Alfuzosin—Nausea—Vandetanib—thyroid cancer	0.00398	0.00398	CcSEcCtD
Alfuzosin—Dyspepsia—Sorafenib—thyroid cancer	0.00398	0.00398	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.0039	0.0039	CcSEcCtD
Alfuzosin—Fatigue—Sorafenib—thyroid cancer	0.00389	0.00389	CcSEcCtD
Alfuzosin—Constipation—Sorafenib—thyroid cancer	0.00386	0.00386	CcSEcCtD
Alfuzosin—Pain—Sorafenib—thyroid cancer	0.00386	0.00386	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00369	0.00369	CcSEcCtD
Alfuzosin—Urticaria—Sorafenib—thyroid cancer	0.00359	0.00359	CcSEcCtD
Alfuzosin—Abdominal pain—Sorafenib—thyroid cancer	0.00357	0.00357	CcSEcCtD
Alfuzosin—Osteoarthritis—Epirubicin—thyroid cancer	0.0034	0.0034	CcSEcCtD
Alfuzosin—Asthenia—Sorafenib—thyroid cancer	0.00324	0.00324	CcSEcCtD
Alfuzosin—Pruritus—Sorafenib—thyroid cancer	0.0032	0.0032	CcSEcCtD
Alfuzosin—Osteoarthritis—Doxorubicin—thyroid cancer	0.00314	0.00314	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Epirubicin—thyroid cancer	0.0031	0.0031	CcSEcCtD
Alfuzosin—Abdominal pain upper—Epirubicin—thyroid cancer	0.0031	0.0031	CcSEcCtD
Alfuzosin—Diarrhoea—Sorafenib—thyroid cancer	0.00309	0.00309	CcSEcCtD
Alfuzosin—Breast disorder—Epirubicin—thyroid cancer	0.00307	0.00307	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00306	0.00306	CcSEcCtD
Alfuzosin—Dizziness—Sorafenib—thyroid cancer	0.00299	0.00299	CcSEcCtD
Alfuzosin—Vomiting—Sorafenib—thyroid cancer	0.00287	0.00287	CcSEcCtD
Alfuzosin—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00287	0.00287	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00287	0.00287	CcSEcCtD
Alfuzosin—Angina pectoris—Epirubicin—thyroid cancer	0.00286	0.00286	CcSEcCtD
Alfuzosin—Rash—Sorafenib—thyroid cancer	0.00285	0.00285	CcSEcCtD
Alfuzosin—Dermatitis—Sorafenib—thyroid cancer	0.00284	0.00284	CcSEcCtD
Alfuzosin—Breast disorder—Doxorubicin—thyroid cancer	0.00284	0.00284	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00283	0.00283	CcSEcCtD
Alfuzosin—Headache—Sorafenib—thyroid cancer	0.00283	0.00283	CcSEcCtD
Alfuzosin—Bronchitis—Epirubicin—thyroid cancer	0.00282	0.00282	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00273	0.00273	CcSEcCtD
Alfuzosin—Nausea—Sorafenib—thyroid cancer	0.00268	0.00268	CcSEcCtD
Alfuzosin—Angina pectoris—Doxorubicin—thyroid cancer	0.00265	0.00265	CcSEcCtD
Alfuzosin—Infestation NOS—Epirubicin—thyroid cancer	0.00262	0.00262	CcSEcCtD
Alfuzosin—Infestation—Epirubicin—thyroid cancer	0.00262	0.00262	CcSEcCtD
Alfuzosin—Drowsiness—Epirubicin—thyroid cancer	0.00262	0.00262	CcSEcCtD
Alfuzosin—Bronchitis—Doxorubicin—thyroid cancer	0.00261	0.00261	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00257	0.00257	CcSEcCtD
Alfuzosin—Jaundice—Epirubicin—thyroid cancer	0.00255	0.00255	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00252	0.00252	CcSEcCtD
Alfuzosin—Sweating—Epirubicin—thyroid cancer	0.00251	0.00251	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00248	0.00248	CcSEcCtD
Alfuzosin—Sinusitis—Epirubicin—thyroid cancer	0.00246	0.00246	CcSEcCtD
Alfuzosin—Infestation—Doxorubicin—thyroid cancer	0.00242	0.00242	CcSEcCtD
Alfuzosin—Drowsiness—Doxorubicin—thyroid cancer	0.00242	0.00242	CcSEcCtD
Alfuzosin—Infestation NOS—Doxorubicin—thyroid cancer	0.00242	0.00242	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00237	0.00237	CcSEcCtD
Alfuzosin—Jaundice—Doxorubicin—thyroid cancer	0.00236	0.00236	CcSEcCtD
Alfuzosin—Rhinitis—Epirubicin—thyroid cancer	0.00236	0.00236	CcSEcCtD
Alfuzosin—Pharyngitis—Epirubicin—thyroid cancer	0.00233	0.00233	CcSEcCtD
Alfuzosin—Sweating—Doxorubicin—thyroid cancer	0.00232	0.00232	CcSEcCtD
Alfuzosin—Urinary tract disorder—Epirubicin—thyroid cancer	0.00232	0.00232	CcSEcCtD
Alfuzosin—Connective tissue disorder—Epirubicin—thyroid cancer	0.00231	0.00231	CcSEcCtD
Alfuzosin—Urethral disorder—Epirubicin—thyroid cancer	0.0023	0.0023	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Alfuzosin—Sinusitis—Doxorubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Alfuzosin—Eye disorder—Epirubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Alfuzosin—Flushing—Epirubicin—thyroid cancer	0.00218	0.00218	CcSEcCtD
Alfuzosin—Cardiac disorder—Epirubicin—thyroid cancer	0.00218	0.00218	CcSEcCtD
Alfuzosin—Rhinitis—Doxorubicin—thyroid cancer	0.00218	0.00218	CcSEcCtD
Alfuzosin—Pharyngitis—Doxorubicin—thyroid cancer	0.00216	0.00216	CcSEcCtD
Alfuzosin—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00215	0.00215	CcSEcCtD
Alfuzosin—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00214	0.00214	CcSEcCtD
Alfuzosin—Angiopathy—Epirubicin—thyroid cancer	0.00213	0.00213	CcSEcCtD
Alfuzosin—Urethral disorder—Doxorubicin—thyroid cancer	0.00213	0.00213	CcSEcCtD
Alfuzosin—Mediastinal disorder—Epirubicin—thyroid cancer	0.00212	0.00212	CcSEcCtD
Alfuzosin—Mental disorder—Epirubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Alfuzosin—Eye disorder—Doxorubicin—thyroid cancer	0.00203	0.00203	CcSEcCtD
Alfuzosin—Flushing—Doxorubicin—thyroid cancer	0.00202	0.00202	CcSEcCtD
Alfuzosin—Cardiac disorder—Doxorubicin—thyroid cancer	0.00202	0.00202	CcSEcCtD
Alfuzosin—Back pain—Epirubicin—thyroid cancer	0.00198	0.00198	CcSEcCtD
Alfuzosin—Angiopathy—Doxorubicin—thyroid cancer	0.00197	0.00197	CcSEcCtD
Alfuzosin—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00196	0.00196	CcSEcCtD
Alfuzosin—Mental disorder—Doxorubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Alfuzosin—Ill-defined disorder—Epirubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Alfuzosin—Malaise—Epirubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Alfuzosin—Vertigo—Epirubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Alfuzosin—Syncope—Epirubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Alfuzosin—Back pain—Doxorubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Alfuzosin—Palpitations—Epirubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Alfuzosin—Loss of consciousness—Epirubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Alfuzosin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Alfuzosin—Arthralgia—Epirubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Alfuzosin—Chest pain—Epirubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Alfuzosin—Discomfort—Epirubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Alfuzosin—Malaise—Doxorubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Alfuzosin—Dry mouth—Epirubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Alfuzosin—Vertigo—Doxorubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Alfuzosin—Syncope—Doxorubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Alfuzosin—Palpitations—Doxorubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Alfuzosin—Oedema—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Alfuzosin—Loss of consciousness—Doxorubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Alfuzosin—Infection—Epirubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Alfuzosin—Shock—Epirubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Alfuzosin—Nervous system disorder—Epirubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Alfuzosin—Thrombocytopenia—Epirubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Alfuzosin—Tachycardia—Epirubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Alfuzosin—Skin disorder—Epirubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Alfuzosin—Hyperhidrosis—Epirubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Alfuzosin—Arthralgia—Doxorubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Alfuzosin—Chest pain—Doxorubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Alfuzosin—Discomfort—Doxorubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Alfuzosin—Dry mouth—Doxorubicin—thyroid cancer	0.00158	0.00158	CcSEcCtD
Alfuzosin—Hypotension—Epirubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Alfuzosin—Oedema—Doxorubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Alfuzosin—Infection—Doxorubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Alfuzosin—Shock—Doxorubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Alfuzosin—Nervous system disorder—Doxorubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Alfuzosin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Alfuzosin—Tachycardia—Doxorubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Alfuzosin—Skin disorder—Doxorubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Alfuzosin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Alfuzosin—Somnolence—Epirubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Alfuzosin—Dyspepsia—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Alfuzosin—Hypotension—Doxorubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Alfuzosin—Fatigue—Epirubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Alfuzosin—Constipation—Epirubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Alfuzosin—Pain—Epirubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Alfuzosin—Feeling abnormal—Epirubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Alfuzosin—Somnolence—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Alfuzosin—Dyspepsia—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Alfuzosin—Fatigue—Doxorubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Alfuzosin—Urticaria—Epirubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Alfuzosin—Pain—Doxorubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Alfuzosin—Constipation—Doxorubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Alfuzosin—Abdominal pain—Epirubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Alfuzosin—Feeling abnormal—Doxorubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Alfuzosin—Urticaria—Doxorubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Alfuzosin—Abdominal pain—Doxorubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Alfuzosin—Asthenia—Epirubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Alfuzosin—Pruritus—Epirubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Alfuzosin—Diarrhoea—Epirubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Alfuzosin—Asthenia—Doxorubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Alfuzosin—Dizziness—Epirubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Alfuzosin—Pruritus—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Alfuzosin—Vomiting—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Alfuzosin—Diarrhoea—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Alfuzosin—Rash—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Alfuzosin—Dermatitis—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Alfuzosin—Headache—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Alfuzosin—Dizziness—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Alfuzosin—Nausea—Epirubicin—thyroid cancer	0.000991	0.000991	CcSEcCtD
Alfuzosin—Vomiting—Doxorubicin—thyroid cancer	0.000982	0.000982	CcSEcCtD
Alfuzosin—Rash—Doxorubicin—thyroid cancer	0.000974	0.000974	CcSEcCtD
Alfuzosin—Dermatitis—Doxorubicin—thyroid cancer	0.000973	0.000973	CcSEcCtD
Alfuzosin—Headache—Doxorubicin—thyroid cancer	0.000967	0.000967	CcSEcCtD
Alfuzosin—Nausea—Doxorubicin—thyroid cancer	0.000917	0.000917	CcSEcCtD
